Zentalis Total Current Liabilities from 2010 to 2024
| ZNTL Stock | USD 11.77 0.80 6.36% |
Total Current Liabilities | First Reported 2010-12-31 | Previous Quarter 69.4 M | Current Value 40.3 M | Quarterly Volatility 21.7 M |
Check Zentalis PharmaceuticalsL financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zentalis main balance sheet or income statement drivers, such as Net Interest Income of 469.1 K, Interest Income of 469.1 K or Depreciation And Amortization of 1.5 M, as well as many exotic indicators such as Price To Sales Ratio of 23.9 K, Dividend Yield of 0.0 or PTB Ratio of 2.15. Zentalis financial statements analysis is a perfect complement when working with Zentalis PharmaceuticalsL Valuation or Volatility modules.
Zentalis | Total Current Liabilities |
Latest Zentalis PharmaceuticalsL's Total Current Liabilities Growth Pattern
Below is the plot of the Total Current Liabilities of Zentalis PharmaceuticalsLlc over the last few years. Total Current Liabilities is an item on Zentalis PharmaceuticalsL balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Zentalis PharmaceuticalsLlc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Zentalis PharmaceuticalsL's Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zentalis PharmaceuticalsL's overall financial position and show how it may be relating to other accounts over time.
| Total Current Liabilities | 10 Years Trend |
|
Total Current Liabilities |
| Timeline |
Zentalis Total Current Liabilities Regression Statistics
| Arithmetic Mean | 20,639,982 | |
| Geometric Mean | 12,800,247 | |
| Coefficient Of Variation | 104.96 | |
| Mean Deviation | 18,084,110 | |
| Median | 6,208,000 | |
| Standard Deviation | 21,663,348 | |
| Sample Variance | 469.3T | |
| Range | 63.2M | |
| R-Value | 0.81 | |
| Mean Square Error | 169.9T | |
| R-Squared | 0.66 | |
| Significance | 0.0002 | |
| Slope | 3,946,772 | |
| Total Sum of Squares | 6570.2T |
Zentalis Total Current Liabilities History
About Zentalis PharmaceuticalsL Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Zentalis PharmaceuticalsL income statement, its balance sheet, and the statement of cash flows. Zentalis PharmaceuticalsL investors use historical funamental indicators, such as Zentalis PharmaceuticalsL's Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although Zentalis PharmaceuticalsL investors may use each financial statement separately, they are all related. The changes in Zentalis PharmaceuticalsL's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Zentalis PharmaceuticalsL's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Zentalis PharmaceuticalsL Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Zentalis PharmaceuticalsL. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Current Liabilities | 69.4 M | 40.3 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Zentalis PharmaceuticalsL in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Zentalis PharmaceuticalsL's short interest history, or implied volatility extrapolated from Zentalis PharmaceuticalsL options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Zentalis PharmaceuticalsL is a strong investment it is important to analyze Zentalis PharmaceuticalsL's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zentalis PharmaceuticalsL's future performance. For an informed investment choice regarding Zentalis Stock, refer to the following important reports:Check out the analysis of Zentalis PharmaceuticalsL Correlation against competitors. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Zentalis Stock analysis
When running Zentalis PharmaceuticalsL's price analysis, check to measure Zentalis PharmaceuticalsL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zentalis PharmaceuticalsL is operating at the current time. Most of Zentalis PharmaceuticalsL's value examination focuses on studying past and present price action to predict the probability of Zentalis PharmaceuticalsL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zentalis PharmaceuticalsL's price. Additionally, you may evaluate how the addition of Zentalis PharmaceuticalsL to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is Zentalis PharmaceuticalsL's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zentalis PharmaceuticalsL. If investors know Zentalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zentalis PharmaceuticalsL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.47) | Return On Assets (0.29) | Return On Equity (0.67) |
The market value of Zentalis PharmaceuticalsL is measured differently than its book value, which is the value of Zentalis that is recorded on the company's balance sheet. Investors also form their own opinion of Zentalis PharmaceuticalsL's value that differs from its market value or its book value, called intrinsic value, which is Zentalis PharmaceuticalsL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zentalis PharmaceuticalsL's market value can be influenced by many factors that don't directly affect Zentalis PharmaceuticalsL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zentalis PharmaceuticalsL's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zentalis PharmaceuticalsL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zentalis PharmaceuticalsL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.